Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit
Authors:
- Marilynn R. FairfaxMFMarilynn R. Fairfax
- Anne Marie QueenanAQAnne Marie Queenan
- Paul R. LephartPLPaul R. Lephart
- Keith S. KayeKKKeith S. Kaye
- Marchaim DrorMDMarchaim Dror
- Nema ArnousNANema Arnous
- Tanaz T. SalimniaTSTanaz T. Salimnia
- Robert A. MitchellRMRobert A. Mitchell
- George AlangadenGAGeorge Alangaden
- Hossein SalimniaHSHossein Salimnia
- 1 November 2011
- journal article
- letter
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 71 (3) , 325-326
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Carbapenemase-Producing Serratia marcescens: the Treatment ConundrumClinical Microbiology Newsletter, 2010
- Occurrence of an SME-2-producing Serratia marcescens isolate in CanadaInternational Journal of Antimicrobial Agents, 2008
- A Fitness Cost Associated With the Antibiotic Resistance Enzyme SME-1 β-LactamaseGenetics, 2007
- SME-2-Producing Serratia marcescens Isolate from SwitzerlandAntimicrobial Agents and Chemotherapy, 2007
- Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999–2005)Diagnostic Microbiology and Infectious Disease, 2006
- SME-3, a Novel Member of the Serratia marcescens SME Family of Carbapenem-Hydrolyzing β-LactamasesAntimicrobial Agents and Chemotherapy, 2006
- Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeDiagnostic Microbiology and Infectious Disease, 2001
- SME-Type Carbapenem-Hydrolyzing Class A β-Lactamases from Geographically Diverse Serratia marcescens StrainsAntimicrobial Agents and Chemotherapy, 2000
- Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6Antimicrobial Agents and Chemotherapy, 1994